- Oral Surgery Partners adds Pennsylvania practice
- The physician ASC ownership playbook
- Oracle Health, 8 health systems must face data breach lawsuit
- Mount Sinai to centralize oversight of its growing AI portfolio
- Duke Health, Texas Health Resources partner with clinical AI company
- Kenya halts US-backed Ebola facility after contempt of court ruling
- Oregon system cuts 45 leadership roles
- Oncology’s ‘last-mile problem’: NCI care bypasses patients who need it most
- Judy Faulkner on AI replacing physicians: ‘I don’t know that I agree’
- ‘Surgical portfolio moves’: Inside the new era of health plan M&A
- Bronson hospital COO exits; interim named
- Fugitive in $3.7B Medicare fraud scheme returned to US after capture
- A new patient safety threat emerging in anesthesia
- $6.5B in false claims, 90 physicians charged in DOJ’s massive healthcare fraud sweep
- Mercy expands pediatric endoscopy, adds sedation-free procedures
- Rock Dental Brands marks record growth during first half of 2026: 4 notes
- The training pipeline that funnels physicians into hospital employment
- Connecticut woman accused of stealing $78K from dental office
- The real physician paycheck: Salary vs. total compensation
- Dental website operator settles class-action privacy lawsuit for $12.7M
- Align Technology appoints new board chair
- The $2.8B problem with CMS’ new joint replacement model
- 1 year since HR 1: How the federal bill is upending oral healthcare
- What’s pushing physicians out of practice 9 years early?
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Psychologists sound alarm on patients using AI for mental health: 5 notes
- American Association for Thoracic Surgery taps new president
- Indiana mental health center expands service area
- Racial gaps persist in mental healthcare for young adults with suicidal thoughts
- Physicians open ophthalmic ASC in Minnesota
- UT Southwestern opens psychiatric hospital
- Hackensack Meridian to upgrade pediatric behavioral health tech
- Oregon State Hospital back in compliance after 2 years
- New Orleans East Hospital breaks ground on 1st inpatient behavioral health unit
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Unpacking CMS' decision to recalculate 2026 MA star ratings after Clover Health ruling
- Michigan hospitals denounce legislation to cap prices, limit mergers
- Incyte drops lawsuit as CMS relents on classification of Opzelura
- Medicare’s AI push snarls patients and doctors in errors and delays
- Midlife Strength Training Linked to Lower Diabetes Risk
- Cadence secures $100M series C to advance AI-powered care for chronic disease
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Hallmark Health Care Solutions launches AI solution to tackle workforce ‘black box’
- Novartis’ ‘Relax Your Tight End’ prostate cancer campaign wins Cannes Lions Pharma Grand Prix
- Illinois passes bill regulating dental reimbursement practices
- The shifting dental care landscape
- Harvard to end faculty dental practice, transfer clinic to private owner due to financial constraints
- MCNA Dental agrees to multimillion-dollar settlement over 2023 ransomware attack
- Optum Behavioral Health names chief medical officer
- OIG flags Pennsylvania behavioral insurer for faulty prior auth denials
- Independence Health to open 28-bed behavioral health unit
- These 'socially responsible' hospitals deliver on quality, value and equity
- A look at Elevance Health's push to streamline clinical reviews
- Whistleblower suit accuses Genentech, Novartis of running decades-long kickback scheme on allergy med Xolair
- Big obesity bets and China's rise fuel potential $2T in 2032 drug sales: Evaluate
- Patient portal messages doubled since 2020, study finds, underscoring challenges to physician workloads
- HCSC unveils Easify Edge plans as alternative employer option
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Half of U.S. adults can't afford healthcare, Gallup poll finds
- Ensemble Health Partners secures strategic growth investment from Thoreau
- Hospital margins inched higher in April, but still remain below 2025
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- CARsgen makes history as China approves world's first CAR-T therapy for solid tumors
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- US to investigate Germany's proposed drug spending reforms
- Alnylam scolded over promotional activity after Pfizer complaint
- Real-world data powers next-gen biopharma
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Prosper AI lands $30M backed by Andreessen Horowitz to build AI workforce for healthcare operations
- Eli Lilly, Novo Nordisk top AI citation share as new report questions DTC spend culture
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- A 5-month sprint: Behind Pfizer’s $10B deal and Innovent’s global pharma ambition
- Rural, independent Kansas hospitals launch clinically integrated network
- FTC orders Aurobindo to divest 4 drugs to complete $250M Lannett acquisition
- Congressional Budget Office calls for more research on No Surprises Act unintended impacts
- HHS opens applications for $700M in mental health, addiction funding, with $96M for new STREETS program
- Ebola Infections Climb, Could Take Year To Contain, Health Officials Say
- Why a deviation investigation still takes two weeks in the age of AI
- Feeling Sleepy During the Day? It Could Be a Warning Sign for High Blood Pressure
- FTC, states sue transgender health association over 'misleading' gender care guidance
- Healthcare organizations still struggle to operationalize AI at scale: Arcadia survey
- Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma
- Major League Pitchers Might Avoid Elbow Injuries By Altering Their Approach, Simulation Suggests
- Birth Control Pills Might Increase Binge Eating Risk, Study Finds
- Women Might Lower Their Heart Risk By Lifting Weights, Study Says
- Personalized Brain Implant Provides Step-By-Step Walking Boost For Parkinson's Patients
- Amid industry’s cell therapy automation push, Cellares and Ori dominate the field: report
- Most Americans Are Surviving Cancer. But The Mental Health Challenges Can Persist.
- Listen to the Latest ‘KFF Health News Minute’
- Readers Curse Medical Debt and Defend Spelling Therapy
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Arrests of Immigrant Parents Create Mental Health Crisis for Children
- Novo's success with oral Wegovy has been fueled by 'familiarity': Spherix
- Preparing for LEAD: Why post-acute visibility is the key to long-term value-based success
- A look at Epic's long-term play to build tech for operations, starting with scheduling
- U.K. Moves To Ban Social Media For Children
- Pregnant Woman Exposed to 45 Common Chemicals, Study Finds
- 4 years after snub, GSK partnership helps Spero get Utebzi across FDA finish line
- Despite 'decent' data, Verastem rethinks options for approved oncology combo in pancreatic cancer
- Why It’s Time to Sunset AI Point Solutions and Consolidate Platforms
- The New Frontier of Care Management: Bridging the Empathy Gap with Intelligence
- Novo Nordisk opens Czech plant and unveils $29M upgrade to China facility
- GSK runs first DTC ad for would-be asthma blockbuster Exdensur
- Novo security breach claimed by hacking groups seeking multi-million-dollar ransoms: reports
- Lower Risk Of Death, Clots Among Autoimmune Patients Taking GLP-1 Drugs
- Surgical Menopause Tied To Worse Sexual And Urinary Symptoms
- Post-Op Delirium Common In Seniors, But Not All Hospitals Screen For It
- Nortiva purrs into action with long-acting Lynx platform salvaged from Langer startup
- Before you build or buy care navigation AI, answer this
- Early-Onset Cancers Are On The Rise. Knowing Your Family History Is Crucial.
- Minimally Invasive Procedure Eases Arthritis Knee Pain, Study Finds
- Tennessee Pharmacies Sell Potent Ivermectin, Led by Anti-Vaccine Doctor Who’s Taken ‘Bucketloads’
- More Americans Are Surviving Cancer. But the Mental Health Challenges Can Persist.
- Democrats Seek To Spotlight Rising Health Costs by Forcing Vote on Trump Regulation
- Big Pharma’s Big Brand: Inside Eli Lilly’s marketing culture
- CDC, FDA Tackle New World Screwworm, Including Drug Authorization
- Lifestyle Changes Can Reduce Your Risk For Multiple Chronic Diseases
- People Walk, Exercise Less After Starting Ozempic, Zepbound
- Family Finances Shape Children’s Brain Development, Study Finds
- At-Home Blood Pressure Monitoring Reduces Risk of Heart Attack, Stroke
- Long-Awaited Rule Aims To Boost ACA Choices While Embracing Higher Deductibles
- Many Men Are Prescribed Testosterone Without Proper Testing
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- Beyond China and Japan: How biopharma is expanding rare disease access across Asia-Pacific
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
Michigan healthcare freedom community forum
Vinayak K. Prasad is an hematologist-oncologist and health researcher with an MSU background. We posted his thoughtful piece on medicine rotting as it becomes more politically partisan four months ago. Now he takes note of the blatant financial corruption which has distorted medicine and health care in the United States - to our detriment:
Medicine is becoming more corrupt
Corruption is the decline of all institutions
Recently, the University of Chicago— my alma matter— announced that their cancer center would be called the Abbvie cancer center after a 75 million dollar donation. Here is the press release.","srcNoWatermark":null,"fullscreen":null,"imageSize":null,"height":942,"width":924,"resizeWidth":null,"bytes":null,"alt":"Image","title":null,"type":null,"href":null,"belowTheFold":false,"topImage":true,"internalRedirect":null,"isProcessing":false}" />
They have the audacity to claim that this move will advance ‘equity’ and ‘culturally competent’ care. To a certain audience, these woke buzzwords justify anything. The truth is money like this will almost surely be spent on catering to the wealthy clients and the University of Chicago has very little interest in the tens of thousands of underserved black residents who are <5 miles from campus. Never has, never will.
Forget the buzzwords, let us focus on what has happened. A historical and venerable university has further prostituted itself to pharma. It is the Abbvie cancer center. What if you are a professor at the Abbvie cancer center and you think Venetoclax is overused (an Abbvie drug), are you free to write papers on that topic? Is there not inherently tacit discouragement?
The reason why many countries have declined is corruption. In some places, university positions can be obtained by bribes. Kickbacks can be given to ensure trials enroll on time. The US, and its institutions have historically risen above corruption, and that has led to greatness. Now it seems that corruption re-enters.
Should an academic university have buildings on campus named after Pharma? Should it have a cancer center, named for Pharma? Why not cut out the middle man? Can Pharma just directly acquire a university?
Already, many cancer centers work by taking tens of millions from Pharma to run trials. At the end of the trial, there is often extra cash. This money creates slush funds that keeps universities running. Universities prostitute themselves to get more trials. They invest in CRCs and IRBs and infrastructure to ensure they provide a good service to pharma. This is what leaders are incentivized to chase.
Many of these trials are unethical. The POLO trial, a famously unethical study that gave placebo to the control arm, was run at the University of Chicago. The university put out a dishonest press release, furthering AZ’s interest.
","srcNoWatermark":null,"fullscreen":null,"imageSize":null,"height":902,"width":1456,"resizeWidth":null,"bytes":337069,"alt":null,"title":null,"type":"image/png","href":null,"belowTheFold":false,"topImage":false,"internalRedirect":null,"isProcessing":false}" />
This is what universities have become. CME [Continuing Medical Education?] companies that work for Pharma. Professors have become Pharma-shills. Running bad trials, and being incapable of thinking critically about research, is de rigueur. Make no mistake, this is a form of corruption. This is the corporatization and prostitution of academia.
The administrators who decide it is OK to name the UofC cancer center the Abbvie cancer center are transient actors. They aren’t the brightest minds or most reflective thinkers. They want to maximize their career opportunities and don’t believe in the transcendent and eternal principles of the academy. I worry that their continued pursuit of corporate money will erode their institutions. I worry that they do not even understand what corruption is.
Finally, it does not escape me that the University of Chicago is not only a prostitute, but a cheap one at that: 75 million for a cancer center is not even that much in the grand scheme of university giving.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.



















","srcNoWatermark":null,"fullscreen":null,"imageSize":null,"height":942,"width":924,"resizeWidth":null,"bytes":null,"alt":"Image","title":null,"type":null,"href":null,"belowTheFold":false,"topImage":true,"internalRedirect":null,"isProcessing":false}" />

","srcNoWatermark":null,"fullscreen":null,"imageSize":null,"height":902,"width":1456,"resizeWidth":null,"bytes":337069,"alt":null,"title":null,"type":"image/png","href":null,"belowTheFold":false,"topImage":false,"internalRedirect":null,"isProcessing":false}" />




